Akèy › Kansè fwa (Kasinòm epatoselilè) › Texas › Dallas
Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Dallas, TX
19 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #89, Dallas
National Liver Cancer Screening Trial
Ap rekriteFaz 4
- UT Southwestern Medical Center and Parkland Hospital, Dallas
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Ap rekriteFaz 1/2
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
Ap rekriteFaz 1 bonè
- University of Texas Southwestern Medical Center, Dallas
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Ap rekriteFaz 2
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Ap rekriteFaz 1/2
- Texas Oncology, P.A., Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Baylor Scott & White Research Institute, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Ap rekriteFaz 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- ak 2 plis
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Ap rekrite
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Ap rekriteFaz 1
- Clinical Trial Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Ap rekriteFaz 1/2
- Harold C. Simmons Comprehensive Cancer Center, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
Ap rekriteEtid obsèvasyon
- Methodist Dallas Medical Center, Dallas
Ligufalimab and Cadonilimab in Advanced Liver Cancers
Ap rekriteFaz 2
- University of Texas Southwestern Medical Center, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Ap rekriteFaz 4
- UT Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Dallas
EGCG for Hepatocellular Carcinoma Chemoprevention
Ap rekriteFaz 2
- UT Southwestern, Dallas
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Ap rekriteFaz 3
- Site 881, Dallas
Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil
- Houston, TX31 etid
- New York City, NY24 etid
- Los Angeles, CA19 etid
- Boston, MA18 etid
- Cleveland, OH18 etid
- Philadelphia, PA16 etid
- Chicago, IL16 etid
- Pittsburgh, PA15 etid
- San Francisco, CA14 etid
- Orange, CA14 etid
- Jacksonville, FL14 etid
- San Antonio, TX13 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè poumon27 etid
- Kansè vejik27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.